Table 2.

Acylcarnitine profile in DCM patients

Variables	DCM	ST2DM	P
	Median (interquartile)	Median (interquartile)
C0, μM	30.95 (24.77–36.84)	24.59 (20.45–31.54)	0.002
C2, μM	12.93 (10.43–16.40)	10.76 (8.87–15.36)	0.039
C3, μM	1.87 (1.43–2.30)	1.65 (1.13–2.18)	0.119
C4, μM	0.23 (0.16–0.34)	0.19 (0.15–0.24)	0.058
C4-OH, μM	0.05 (0.03–0.10)	0.05 (0.03–0.07)	0.275
C4DC, μM	0.41 (0.21–0.85)	0.30 (0.24–0.41)	0.088
C5, μM	0.13 (0.09–0.16)	0.14 (0.11–0.19)	0.042
C5-OH, μM	0.19 (0.13–0.28)	0.18 (0.14–0.26)	0.923
C5:1, μM	0.03 (0.02–0.07)	0.04 (0.02–0.06)	0.774
C6, μM	0.07 (0.06–0.09)	0.07 (0.05–0.08)	0.236
C8, μM	0.11 (0.07–0.17)	0.06 (0.04–0.08)	< 0.001
C10, μM	0.16 (0.08–0.27)	0.05 (0.03–0.07)	< 0.001
C12, μM	0.08 (0.06–0.10)	0.05 (0.03–0.07)	< 0.001
C14, μM	0.08 (0.05–0.11)	0.06 (0.04–0.08)	0.002
C14-OH, μM	0.04 (0.02–0.07)	0.03 (0.02–0.04)	0.016
C14DC, μM	0.03 (0.02–0.05)	0.02 (0.02–0.04)	0.362
C16, μM	1.02 (0.76–1.42)	0.78 (0.62–0.92)	< 0.001
C16-OH, μM	0.02 (0.02–0.03)	0.02 (0.02–0.03)	0.668
C16:1-OH, μM	0.05 (0.03–0.07)	0.04 (0.03–0.05)	0.030
C18, μM	0.54 (0.38–0.71)	0.48 (0.36–0.59)	0.133
C20, μM	0.03 (0.02–0.05)	0.02 (0.02–0.03)	0.012
C22, μM	0.06 (0.03–0.08)	0.05 (0.04–0.07)	0.319
C24, μM	0.04 (0.03–0.06)	0.03 (0.02–0.04)	0.036
C26, μM	0.03 (0.02–0.04)	0.03 (0.02–0.04)	< 0.001
C14:1, μM	0.10 (0.06–0.16)	0.06 (0.03–0.08)	< 0.001

The content of 25 acylcarnitines data, presented with a median with IQR and compared between groups using the Wilcoxon signed-rank test